Clemastine fumarate
| Status | Commercial |
| Development phase | |
| Therapeutic cat. | Other |
| Polymorphic form | Substance does not show polymorphism |
| CAS No. | 14976-57-9 |
| Reference Product | |
| Injectable Form | |
| EU DMF readiness |  |
| CEP | |
| CHINESE DMF | |
| JAPANESE DMF | |
| KOREAN DMF | |
| CANADIAN DMF | |
| CADIFA | |
| US DMF readiness | |
| OEB No. | |
| Samples |
Drug description
Clemastine is an antihistamine that reduces the effects of natural chemical histamine in the body. Histamine can produce symptoms of sneezing, itching, watery eyes, and runny nose. Clemastine is used to treat sneezing, runny nose, watery eyes, itching, and other cold or allergy symptoms. Clemastine is may also be used for purposes not listed in this medication guide.
Polpharma API
- Long experience in in-house commercial manufacturing
- All intermediates produced in-house
Disclaimer
Products protected by patents (SPC) in Poland are developed solely for the purpose of Regulatory Submissions or R&D purposes intended to support Regulatory Submissions. These products are not offered for sale or made available in countries where such products are subject to patent (SPC) protection and where the offer for sale or any related activity constitutes patent infringement. It is within the buyer’s responsibility and liability to check the patent situation of the product in the import market(s).
